The stock of PharMerica Corporation (NYSE:PMC) is a huge mover today! The stock decreased 3.48% or $0.75 on November 8, hitting $20.8. About 594,252 shares traded hands or 76.59% up from the average. PharMerica Corporation (NYSE:PMC) has declined 2.05% since April 6, 2016 and is downtrending. It has underperformed by 4.00% the S&P500.
The move comes after 6 months negative chart setup for the $641.40M company. It was reported on Nov, 8 by Barchart.com. We have $19.34 PT which if reached, will make NYSE:PMC worth $44.90M less.
PharMerica Corporation (NYSE:PMC) Ratings Coverage
Out of 3 analysts covering Pharmerica (NYSE:PMC), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. Pharmerica has been the topic of 6 analyst reports since August 10, 2015 according to StockzIntelligence Inc. The firm has “Buy” rating given on Tuesday, June 7 by Bank of America. UBS upgraded PharMerica Corporation (NYSE:PMC) on Monday, August 10 to “Neutral” rating. The stock of PharMerica Corporation (NYSE:PMC) has “Outperform” rating given on Monday, August 10 by Barrington Research. The stock of PharMerica Corporation (NYSE:PMC) has “Hold” rating given on Monday, August 17 by Zacks. On Tuesday, May 10 the stock rating was maintained by Barrington Research with “Outperform”. The firm has “Neutral” rating given on Monday, March 14 by UBS.
According to Zacks Investment Research, “PharMerica Corporation is an institutional pharmacy services provider dedicated to providing quality customer service and innovative pharmacy solutions to institutional customers and patients in long-term care settings. PharMerica is a public company formed through the combination of the institutional pharmacy business of national healthcare services company Kindred Healthcare, Inc. and pharmaceutical services company AmerisourceBergen Corporation. As a result of this combination, PharMerica ranks as an industry-leading U.S. provider of institutional pharmacy services in terms of annual revenues.”
Insitutional Activity: The institutional sentiment decreased to 1.08 in 2016 Q2. Its down 0.03, from 1.11 in 2016Q1. The ratio fall, as 18 funds sold all PharMerica Corporation shares owned while 53 reduced positions. 27 funds bought stakes while 50 increased positions. They now own 28.21 million shares or 1.34% less from 28.59 million shares in 2016Q1.
Endurant Cap Mgmt Ltd Partnership last reported 9,390 shares in the company. Moreover, Los Angeles Cap & Equity Inc has 0% invested in PharMerica Corporation (NYSE:PMC) for 20,639 shares. Ahl Partners Limited Liability Partnership holds 0.01% of its portfolio in PharMerica Corporation (NYSE:PMC) for 8,965 shares. James Invest Research has invested 0% of its portfolio in PharMerica Corporation (NYSE:PMC). Tfs Cap Limited Com reported 77,166 shares or 0.35% of all its holdings. State Board Of Administration Of Florida Retirement Sys, a Florida-based fund reported 57,717 shares. The Massachusetts-based Boston Prns has invested 0.01% in PharMerica Corporation (NYSE:PMC). South Dakota Council has 72,885 shares for 0.04% of their US portfolio. Sei Invests holds 0% or 6,638 shares in its portfolio. Capstone Asset Management Company owns 12,321 shares or 0.01% of their US portfolio. California Public Employees Retirement System accumulated 0% or 117,300 shares. Texas Permanent School Fund owns 23,500 shares or 0.01% of their US portfolio. Counselors Of Maryland Lc has 10,293 shares for 0.01% of their US portfolio. Redwood Investments Limited last reported 0.18% of its portfolio in the stock. The Germany-based Allianz Asset Ag has invested 0% in PharMerica Corporation (NYSE:PMC).
More notable recent PharMerica Corporation (NYSE:PMC) news were published by: Businesswire.com which released: “PharMerica Corporation Announces Planned Retirement of Chief Financial Officer …” on August 09, 2016, also Businesswire.com with their article: “PharMerica Corporation Announces Fourth Quarter and Year-End 2015 Earnings …” published on February 09, 2016, Fool.com published: “Why PharMerica Soared 13.4% Today” on August 25, 2016. More interesting news about PharMerica Corporation (NYSE:PMC) were released by: Prnewswire.com and their article: “PharMerica Joins DC-Based Senior Care Pharmacy Coalition (SCPC) Citing Need …” published on August 16, 2016 as well as Businesswire.com‘s news article titled: “PharMerica Provides Update on AmerisourceBergen Litigation” with publication date: April 04, 2016.
PMC Company Profile
PharMerica Corporation, incorporated on October23, 2006, is an institutional pharmacy services company. The Firm services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. The Firm has three divisions: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. The Company’s core business institutional pharmacy segment provides pharmacy services and products to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. The Company’s specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings. The Company’s specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.